These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 8185669)
1. Identification of a single (FP) receptor associated with prostanoid-induced Ca2+ signals in Swiss 3T3 cells. Woodward DF; Lawrence RA Biochem Pharmacol; 1994 Apr; 47(9):1567-74. PubMed ID: 8185669 [TBL] [Abstract][Full Text] [Related]
2. Identification of the FP-receptor as a discrete entity by radioligand binding in biosystems that exhibit different functional rank orders of potency in response to prostanoids. Woodward DF; Fairbairn CE; Lawrence RA Adv Exp Med Biol; 1997; 400A():223-7. PubMed ID: 9547561 [TBL] [Abstract][Full Text] [Related]
3. Radioligand binding analysis of receptor subtypes in two FP receptor preparations that exhibit different functional rank orders of potency in response to prostaglandins. Woodward DF; Fairbairn CE; Krauss AH; Lawrence RA; Protzman CE J Pharmacol Exp Ther; 1995 Apr; 273(1):285-7. PubMed ID: 7714778 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2. Giles H; Bolofo ML; Lydford SJ; Martin GR Br J Pharmacol; 1991 Oct; 104(2):541-9. PubMed ID: 1665742 [TBL] [Abstract][Full Text] [Related]
5. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells. Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice. Minami T; Okuda-Ashitaka E; Mori H; Ito S; Hayaishi O J Pharmacol Exp Ther; 1996 Sep; 278(3):1146-52. PubMed ID: 8819497 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin moieties that determine receptor binding specificity in the bovine corpus luteum. Anderson LE; Schultz MK; Wiltbank MC J Reprod Fertil; 1999 May; 116(1):133-41. PubMed ID: 10505064 [TBL] [Abstract][Full Text] [Related]
8. Studies on the characterisation of prostanoid receptors: a proposed classification. Kennedy I; Coleman RA; Humphrey PP; Levy GP; Lumley P Prostaglandins; 1982 Nov; 24(5):667-89. PubMed ID: 6131499 [TBL] [Abstract][Full Text] [Related]
9. Individual variations of prostanoid agonist responses in rabbit aorta: evidence for the independent regulation of prostanoid receptor subtypes. Keith RA; Salama AI Br J Pharmacol; 1987 Sep; 92(1):133-48. PubMed ID: 3664085 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 and F2 alpha binding sites in the bovine iris ciliary body. Csukas S; Bhattacherjee P; Rhodes L; Paterson CA Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2237-45. PubMed ID: 8389343 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Meja KK; Barnes PJ; Giembycz MA Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541 [TBL] [Abstract][Full Text] [Related]
12. Further studies on ocular responses to DP receptor stimulation. Woodward DF; Spada CS; Hawley SB; Williams LS; Protzman CE; Nieves AL Eur J Pharmacol; 1993 Jan; 230(3):327-33. PubMed ID: 8440310 [TBL] [Abstract][Full Text] [Related]
13. Type-1 and type-2 astrocytes are distinct targets for prostaglandins D2, E2, and F2 alpha. Ito S; Sugama K; Inagaki N; Fukui H; Giles H; Wada H; Hayaishi O Glia; 1992; 6(1):67-74. PubMed ID: 1324890 [TBL] [Abstract][Full Text] [Related]
14. Marked differential effects of prostanoid metabolites on rabbit intraocular pressure. Woodward DF; Williams LS; Chen J Ophthalmic Res; 1989; 21(6):428-35. PubMed ID: 2626239 [TBL] [Abstract][Full Text] [Related]
15. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes. Crankshaw DJ; Gaspar V J Reprod Fertil; 1995 Jan; 103(1):55-61. PubMed ID: 7535849 [TBL] [Abstract][Full Text] [Related]
17. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Giles H; Leff P; Bolofo ML; Kelly MG; Robertson AD Br J Pharmacol; 1989 Feb; 96(2):291-300. PubMed ID: 2924081 [TBL] [Abstract][Full Text] [Related]
18. Evidence for thromboxane receptor mediated contraction of guinea-pig and human airways in vitro by prostaglandin (PG) D2, 9 alpha,11 beta-PGF2 and PGF2 alpha. Featherstone RL; Robinson C; Holgate ST; Church MK Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):439-43. PubMed ID: 2142256 [TBL] [Abstract][Full Text] [Related]
19. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques. Sharif NA; Davis TL J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132 [TBL] [Abstract][Full Text] [Related]
20. The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C. Hamid-Bloomfield S; Payne AN; Petrovic AA; Whittle BJ Br J Pharmacol; 1990 Aug; 100(4):761-6. PubMed ID: 2119842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]